References
- Mouneimne G, Hansen SD, Selfors LM, Petrak L, Hickey MM, Gallegos LL, Simpson KJ, Lim J, Gertler FB, Hartwig JH, et al. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 2012; 22:615–30; PMID:23153535; https://doi.org/10.1016/j.ccr.2012.09.027
- Janke J, Schluter K, Jandrig B, Theile M, Kölble K, Arnold W, Grinstein E, Schwartz A, Estevéz-Schwarz L, Schlag PM, et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 2000; 191:1675–86; PMID:10811861; https://doi.org/10.1084/jem.191.10.1675
- Ding Z, Joy M, Bhargava R, Gunsaulus M, Lakshman N, Miron-Mendoza M, Petroll M, Condeelis J, Wells A, Roy P. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene 2014; 33:2065–74; PMID:23686314; https://doi.org/10.1038/onc.2013.166
- Zou L, Jaramillo M, Whaley D, Wells A, Panchapakesa V, Das T, Roy P. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer 2007; 97:1361–71; PMID:17940506; https://doi.org/10.1038/sj.bjc.6604038
- Wittenmayer N, Jandrig B, Rothkegel M, Schlüter K, Arnold W, Haensch W, Scherneck S, Jockusch BM. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell 2004; 15:1600–8; PMID:14767055; https://doi.org/10.1091/mbc.E03-12-0873
- Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell 2014; 14:275–91; PMID:24607403; https://doi.org/10.1016/j.stem.2014.02.006
- Zheng J, Lu Z, Kocabas F, Böttcher RT, Costell M, Kang X, Liu X, Deberardinis RJ, Wang Q, Chen GQ, et al. Profilin 1 is essential for retention and metabolism of mouse hematopoietic stem cells in bone marrow. Blood 2014; 123:992–1001; PMID:24385538; https://doi.org/10.1182/blood-2013-04-498469
- Kim MJ, Lee YS, Han GY, Lee HN, Ahn C, Kim CW. Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells. Biosci Biotechnol Biochem 2015; 79:1438–46; PMID:25964982; https://doi.org/10.1080/09168451.2015.1043118
- Zou L, Hazan R, Roy P. Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner. Cell Motil Cytoskeleton 2009; 66:1048–56; PMID:19593789; https://doi.org/10.1002/cm.20407
- Joy M, Gau D, Castellucci N, Prywes R, Roy P. The Myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms. J Biol Chem 2017; 292, 11777–11791; PMID:28546428; https://doi.org/10.1074/jbc.M117.781104
- Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res: BCR 2006; 8:R59; PMID:17062128; https://doi.org/10.1186/bcr1610
- Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, Kuperwasser C. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A 2010; 107:21737–42; PMID:21098263; https://doi.org/10.1073/pnas.1007863107
- Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R, Martin AG. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 2012; 31:1354–65; PMID:21822303; https://doi.org/10.1038/onc.2011.338
- Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, Medina D, Fässler R, Thiery JP, Glukhova MA. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nature Cell Biol 2008; 10:716–22; PMID:18469806; https://doi.org/10.1038/ncb1734
- Chen L, Fan J, Chen H, Meng Z, Chen Z, Wang P, Liu L. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Sci Rep 2014; 4:5911; PMID:25081383; https://doi.org/10.1038/srep05911
- Chung SS, Aroh C, Vadgama JV. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells. PloS One 2013; 8:e83971; PMID:24386318; https://doi.org/10.1371/journal.pone.0083971
- Lu H, Clauser KR, Tam WL, Fröse J, Ye X, Eaton EN, Reinhardt F, Donnenberg VS, Bhargava R, Carr SA, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol 2014; 16:1105–17; PMID:25266422; https://doi.org/10.1038/ncb3041
- Alam M, Rajabi H, Ahmad R, Jin C, Kufe D. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells. Oncotarget 2014; 5:2622–34; PMID:24770886; https://doi.org/10.18632/oncotarget.1848
- Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 2014;20:332–42; PMID:24667139; https://doi.org/10.1016/j.molmed.2014.02.007
- Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003; 163:2113–26; PMID:14578209; https://doi.org/10.1016/S0002-9440(10)63568-7
- Rao T, Ranger JJ, Smith HW, Lam SH, Chodosh L, Muller WJ. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression. Breast Cancer Res: BCR 2014; 16:R11; PMID:24457046; https://doi.org/10.1186/bcr3603
- Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001; 10:545–53; PMID:11817542; https://doi.org/10.1023/A:1013063514007
- Lu P, Ewald AJ, Martin GR, Werb Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 2008; 321:77–87; PMID:18585375; https://doi.org/10.1016/j.ydbio.2008.06.005
- White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004; 6:159–70; PMID:15324699; https://doi.org/10.1016/j.ccr.2004.06.025
- Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, Muller WJ. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A 2007; 104:20302–7; PMID:18056629; https://doi.org/10.1073/pnas.0710091104
- Alam M, Ahmad R, Rajabi H, Kharbanda A, Kufe D. MUC1-C oncoprotein activates ERK–>C/EBPbeta signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells. J Biol Chem 2013; 288:30892–903; PMID:24043631; https://doi.org/10.1074/jbc.M113.477158
- Zhang L, Vlad A, Milcarek C, Finn OJ. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms. Cancer Immunol Immunother 2013; 62:423–35; PMID:22941036; https://doi.org/10.1007/s00262-012-1325-2
- Frantzi M, Klimou Z, Makridakis M, Zoidakis J, Latosinska A, Borràs DM, Janssen B, Giannopoulou I, Lygirou V, Lazaris AC, et al. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models. Oncotarget 2016; 7:70750–68; PMID:27683119
- Cheng YJ, Zhu ZX, Zhou JS, Hu ZQ, Zhang JP, Cai QP, Wang LH. Silencing profilin-1 inhibits gastric cancer progression via integrin beta1/focal adhesion kinase pathway modulation. World J Gastroenterol 2015; 21:2323–35; PMID:25741138; https://doi.org/10.3748/wjg.v21.i8.2323
- Shen K, Xi Z, Xie J, Wang H, Xie C, Lee CS, Fahey P, Dong Q, Xu H. Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1. Oncotarget 2016; 7:56650–63; PMID:27494863
- Ding Z, Bae YH, Roy P. Molecular insights on context-specific role of profilin-1 in cell migration. Cell Adh Migr 2012; 6:442–9; https://doi.org/10.4161/cam.21832
- Zou L, Ding Z, Roy P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. J Cell Physiol 2010; 223:623–9; PMID:20143334.
- Yao W, Cai X, Liu C, Qin Y, Cheng H, Ji S, Xu W, Wu C, Chen T, Xu J, et al. Profilin 1 potentiates apoptosis induced by staurosporine in cancer cells. Curr Mol Med 2013; 13:417–28; PMID:23331014
- Bottcher RT, Wiesner S, Braun A, Wimmer R, Berna A, Elad N, Medalia O, Pfeifer A, Aszódi A, Costell M, et al. Profilin 1 is required for abscission during late cytokinesis of chondrocytes. The EMBO J 2009; 28:1157–69; PMID:19262563; https://doi.org/10.1038/emboj.2009.58
- Gau DM, Lesnock JL, Hood BL, Bhargava R, Sun M, Darcy K, Luthra S, Chandran U, Conrads TP, Edwards RP, et al. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. Cell Cycle 2015; 14:1884–92; PMID:25927284; https://doi.org/10.1080/15384101.2015.1036203